Elite Wealth Management’s Amgen AMGN Stock Holding History

Elite Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-119	Closed	-$1K	–	657
2014 Q2	$1K	Buy	+119	New	+$13.8K	﹤0.01%	412

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Elite Wealth Management's AMGN Position: Q1 2025 in Review

Elite Wealth Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,203 shares — an estimated $314K sold.

Elite Wealth Management first reported a position in AMGN in Q2 2013 and held it in 43 quarters. The position peaked at $1.65M in Q2 2015. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

Elite Wealth Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
Elite Wealth Management sold 1,203 Amgen shares in Q1 2025, an estimated $314K.
Elite Wealth Management first reported a position in Amgen in Q2 2013 and held it in 43 quarters.
Elite Wealth Management's Amgen position peaked at $1.65M in Q2 2015.
2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Elite Wealth Management's 13F filing for Q1 2025, filed 2 May 2025.